title: Killing effect of TNF-mediated by conditionally replicating adenovirus on esophageal cancer and lung cancer cell lines.
abstract: OBJECTIVE
  The killing effect of TNF mediated by conditionally replicating adenovirus SG502 on human cancer cell lines was assessed by in vivo and in vitro experiments.
  
  
  METHODS
  The recombinant adenovirus SG502-TNF was used to infect human lung cancer cell line A549 and human esophageal cancer cell line TE-1. The expression of the exogenous gene and its inhibitory effect on the tumor cell lines were thus detected. Tumor transplantation experiment was performed in mice with the purpose of assessing the inhibitory effect of the adenovirus on tumor cells and tumor formation. The targeting of the adenovirus and the mechanism of tumor inhibition were discussed by in vivo imaging technology, HE staining and TUNEL assay.
  
  
  RESULTS
  Recombinant adenovirus SG502-TNF targeted the tumor cells specifically with stable expression of TNF, which produced a killing effect on tumor cells by regulating the apoptotic signaling pathway.
  
  
  CONCLUSIONS
  Recombinant adenovirus SG502-TNF possessed significant killing effect on TE-1 cells either in vivo or in vitro. This finding demonstrated the potential clinical application of adenovirus SG502.
authors.affiliation: Department of Thoracic Surgery, Chongqing Cancer Institute Chongqing, China.
authors.forename: Yue-Quan
authors.initials: YQ
authors.lastname: Jiang
authors.affiliation: Department of Thoracic Surgery, Chongqing Cancer Institute Chongqing, China.
authors.forename: Zhi
authors.initials: Z
authors.lastname: Zhang
authors.affiliation: Department of Thoracic Surgery, Chongqing Cancer Institute Chongqing, China.
authors.forename: Hua-Rong
authors.initials: HR
authors.lastname: Cai
authors.affiliation: Department of Thoracic Surgery, Chongqing Cancer Institute Chongqing, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Zhou
mesh_terms: D000256:Adenoviridae / Q000235:genetics / Q000254:growth & development* / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D004938:Esophageal Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy* / Q000821:virology; D005240:Feasibility Studies; D015972:Gene Expression Regulation, Neoplastic; D015967:Gene Expression Regulation, Viral; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy* / Q000821:virology; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D050130:Oncolytic Virotherapy / Q000379:methods*; D050504:Oncolytic Viruses / Q000235:genetics / Q000254:growth & development* / Q000378:metabolism; D019098:Telomerase / Q000096:biosynthesis / Q000235:genetics; D013997:Time Factors; D047368:Tumor Burden; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis* / Q000235:genetics; D014779:Virus Replication; D023041:Xenograft Model Antitumor Assays
chemical_list: D014409:Tumor Necrosis Factor-alpha; C509186:TERT protein, human; D019098:Telomerase
keywords: Adenovirus; cancer cells; tumor necrosis factor
references.citation: Gene Ther. 2005 Nov;12(22):1608-17
references.pmid: 16034456
references.citation: Cancer Res. 1997 Jul 1;57(13):2559-63
references.pmid: 9205053
references.citation: Mol Ther. 2006 Jul;14(1):107-17
references.pmid: 16690359
references.citation: J Gene Med. 2006 Jun;8(6):679-89
references.pmid: 16570242
references.citation: Gene Ther. 2007 Jan;14(1):58-67
references.pmid: 16900223
references.citation: Mol Cancer Ther. 2007 Oct;6(10):2728-36
references.pmid: 17938266
references.citation: Clin Cancer Res. 2009 Mar 1;15(5):1664-73
references.pmid: 19240175
references.citation: BMC Cancer. 2010;10:584
references.pmid: 20977779
references.citation: Mol Ther. 2011 Mar;19(3):490-9
references.pmid: 21081903
references.citation: J Control Release. 2010 Nov 20;148(1):e124
references.pmid: 21529594
references.citation: Acta Virol. 2012;56(4):345-7
references.pmid: 23237092
references.citation: PLoS One. 2013;8(9):e73555
references.pmid: 24073198
references.citation: J Virol. 2014 Dec;88(24):14451-7
references.pmid: 25297992
references.citation: Cancer Res. 2001 Aug 15;61(16):5959-63
references.pmid: 11507034
references.citation: Cancer Res. 2002 Aug 1;62(15):4273-81
references.pmid: 12154029
references.citation: Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):285-92
references.pmid: 14734481
references.citation: Cancer Res. 2004 May 15;64(10):3638-44
references.pmid: 15150123
references.citation: Cancer Gene Ther. 2007 Jan;14(1):105-16
references.pmid: 17024232